Newsbenzinga
Nexalin Technology Completes 8-Week Clinical Study Of Neurostimulation Protocol In Adults With Generalized Anxiety Disorder, Comorbid Insomnia
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…